MANGALAM

Mangalam Drugs And Organics Ltd.

NSE: MANGALAM

BSE: 532637

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

27.70+0.8 (+3.09%)

21 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

43.84

P/E (TTM)

P/B

0.43

P/S (TTM)

0.19

EV/EBITDA

CAPE (5Y)

ROE (TTM)

-35.23

ROCE (TTM)

-14.61

ROA (TTM)

-13.03

Avg 3Y ROE

-12.26

Earnings 3Y CAGR

-50.29

Sales 3Y CAGR

-12.77

Sales 5Y CAGR

-9.42

Debt/Equity

1.02

Consensus TP

Strong Buy %

Promoter Holding

35.65

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Mangalam Drugs And Organics Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -89.26% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low and declining ROE

The company reported low ROE of -35.23% for 12-month ended 30 Jun 2026 and ROE declined by -3984 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of -11.54% for 12-month ended 30 Jun 2026 and operating margin declined by -1352 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -22.27% for 12-month ended 30 Jun 2026 and the growth was 32.86 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value -22.27

-99.6111701.8

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -291.41% for 12-month ended 30 Jun 2026 and the growth was 298.61 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Reasonable Debt to Equity, but increasing

The company has reasonable Debt to Equity of 1.02 as on 30 Jun 2026 but Debt to Equity increased by 0.38 in the last 1 year

What is Debt to Equity?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Mangalam Drugs And Organics Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Mangalam Drugs And Organics Ltd. Shareholding Pattern

Quarterly breakdown of Mangalam Drugs And Organics Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	50.53	50.53	50.53	50.53	50.53	50.53	50.53	50.53	50.53	50.42	50.42	50.32	50.32	50.32	50.32	50.32	50.32	50.31	50.30	50.30	50.30	50.30	50.30	35.64	35.65	35.65
Indian Promoter	50.53	50.53	50.53	50.53	50.53	50.53	50.53	50.53	50.53	50.42	50.42	50.32	50.32	50.32	50.32	50.32	50.32	50.31	50.30	50.30	50.30	50.30	50.30	35.64	35.65	35.65
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.11	0.11	0.10	0.10	0.10	0.10	0.10	0.10	0.26	0.21	0.11	0.11	0.47	0.53	0.11	0.13	0.32	0.11
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.26	0.21	0.11	0.11	0.47	0.53	0.11	0.13	0.32	0.11
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	49.46	49.46	49.46	49.46	49.46	49.46	49.46	49.46	49.36	49.47	49.48	49.58	49.58	49.58	49.58	49.58	49.42	49.47	49.58	49.58	49.23	49.16	49.58	64.22	64.02	64.24
Bodies Corporate	1.30	1.22	1.46	1.59	1.33	1.65	0.68	1.90	2.22	1.89	2.12	1.97	1.93	1.93	2.02	2.04	2.31	2.11	1.97	2.13	1.90	1.71	1.70	1.79	0.90	0.85
Others (incl. Retail) No. of shareholders	48.16 17,757	48.24 18,361	48.00 19,567	47.87 19,146	48.13 20,414	47.81 21,723	48.78 20,969	47.56 20,569	47.14 19,989	47.58 18,887	47.36 18,368	47.61 17,808	47.65 17,848	47.65 17,795	47.56 17,883	47.54 18,521	47.11 19,078	47.36 19,214	47.61 19,414	47.45 19,580	47.33 19,608	47.45 19,642	47.88 19,801	62.43 21,145	63.12 25,054	63.39 24,379

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Mangalam Drugs And Organics Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Mangalam Drugs And Organics Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Chandrakanta M. Dhoot Promoter Group	June-2022	Market Sale (Disposal) 8th Jun 2022	2.72 %	₹ 139.54	9.00 k	₹ 12.56 lac
Shweta G. Dhoot Promoter Group	June-2022	Market Sale (Disposal) 8th Jun 2022	0.12 %	₹ 142.47	9.00 k	₹ 12.82 lac

Corporate Actions

History of Mangalam Drugs And Organics Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.50/share
Record date: 22nd Dec 2017Ex-date: 21st Dec 2017
Announced on: 12th Dec 2017
Dividend₹ 0.20/share
Record date: 21st Sep 2006Ex-date: 19th Sep 2006
Announced on: 30th Jun 2006
Dividend₹ 0.20/share
Record date: 1st Sep 2005Ex-date: 30th Aug 2005
Announced on: 13th Jun 2005

Company Profile

Overview of Mangalam Drugs And Organics Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Companys Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products inclu...

Key personnel

Mr. Jeevan Mukund Dalvi

Chief Financial Officer

Ms. Shweta Patel

Compliance Officer, Company Secretary

Shri. Govardhan Murlidhar DhootD

Executive Chairman of the Board, Managing Director

Shri. Brijmohan M. DhootD

Whole-time Director

Mr. Rakesh K. MilwaniD

Non-Executive and Non-Independent Director

Smt. Nidhi S. MundadaD

Non-Executive Independent Director

Dr. Praveen SaxenaD

Non-Executive Independent Director

Dr. Praveen SaxenaD

Non-Executive Independent Director

Incorporated on

18 Apr 1972

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

26 May 2005

Free Float

98,62,133

Website

https://www.mangalamdrugs.com/

Phone no.

+912222616200

Address

3RD FLOOR, RUPAM BUILDING 239, P. DMELLO ROAD, , 400001, India

Frequently Asked Questions

What is the current share price of Mangalam Drugs And Organics Ltd.?

The current share price of Mangalam Drugs And Organics Ltd. is ₹ 27.70 as of 21 Aug 2026.

What is the market capitalisation of Mangalam Drugs And Organics Ltd.?

The market capitalisation of Mangalam Drugs And Organics Ltd. stands at ₹ 43.84 Cr.

What is the PE ratio of Mangalam Drugs And Organics Ltd.?

The Price-to-Earnings (PE) ratio of Mangalam Drugs And Organics Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Mangalam Drugs And Organics Ltd.?

Mangalam Drugs And Organics Ltd. has a Return on Equity (ROE) of -35.23% and a Return on Capital Employed (ROCE) of -14.61% as per the latest financial reports.

What is the 52-week high and low of Mangalam Drugs And Organics Ltd.?

The 52-week high of Mangalam Drugs And Organics Ltd. is - and the 52-week low is -.

What is the dividend yield of Mangalam Drugs And Organics Ltd.?

The dividend yield of Mangalam Drugs And Organics Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Mangalam Drugs And Organics Ltd.?

Foreign Institutional Investors (FII) hold 0.11%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 63.39% of Mangalam Drugs And Organics Ltd. shares.

What sector does Mangalam Drugs And Organics Ltd. belong to?

Mangalam Drugs And Organics Ltd. operates in the Healthcare sector.

What is the beta of Mangalam Drugs And Organics Ltd.?

The beta of Mangalam Drugs And Organics Ltd. is 0.58, indicating its price volatility relative to the broader market. Over the past 1 year, Mangalam Drugs And Organics Ltd. has delivered an absolute return of -62.82%.

What is the RSI of Mangalam Drugs And Organics Ltd.?

The 14-day Relative Strength Index (RSI) of Mangalam Drugs And Organics Ltd. is 52.44, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Mangalam Drugs And Organics Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Mangalam Drugs And Organics Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile

Corporate Actions